0 NASDAQ Companies - September 2, 2020Immunovant Announces Pricing of Public OfferingNEW YORK, Sept. 02, 2020 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT) today announced the pricing of its underwritten public […]Read More
0 NASDAQ Companies - September 2, 2020AlloVir Reports Second Quarter 2020 Financial ResultsCAMBRIDGE, Mass., Sept. 02, 2020 (GLOBE NEWSWIRE) — AlloVir (Nasdaq: ALVR), a late clinical-stage cell therapy company, today reported financial […]Read More
0 NASDAQ Companies - September 2, 2020XOMA to Present at Upcoming Investor ConferencesEMERYVILLE, Calif., Sept. 02, 2020 (GLOBE NEWSWIRE) — XOMA Corporation (NASDAQ: XOMA) announced today its Chief Executive Officer, Jim Neal, […]Read More
0 NASDAQ Companies - September 2, 2020G1 Therapeutics to Participate in Four Investor Conferences in September 2020RESEARCH TRIANGLE PARK, N.C., Sept. 02, 2020 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today […]Read More
0 NASDAQ Companies - September 2, 2020Akoustis Appoints Former Grant Thornton, CEO, J. Michael McGuire, to its Board of DirectorsCharlotte, N.C., Sept. 02, 2020 (GLOBE NEWSWIRE) — Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) […]Read More
0 NASDAQ Companies - September 2, 2020Opera joins the Emerging Payments Association EU as founding memberOSLO, Norway, Sept. 02, 2020 (GLOBE NEWSWIRE) — Opera [NASDAQ: OPRA] is joining the Emerging Payments Association EU, a membership […]Read More
0 NASDAQ Companies - September 2, 2020CareDx to Participate at Upcoming ConferencesSOUTH SAN FRANCISCO, Calif., Sept. 02, 2020 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on […]Read More
0 NASDAQ Companies - September 2, 2020TELA Bio to Participate at Upcoming ConferencesMALVERN, Pa., Sept. 02, 2020 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”), a commercial-stage medical technology company focused on designing, […]Read More
0 NASDAQ Companies - September 2, 2020Iterum Therapeutics Announces Revised Results of Rights OfferingDUBLIN, Ireland and CHICAGO, Sept. 02, 2020 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical […]Read More
0 NASDAQ Companies - September 2, 2020Trevena, Inc. to Present at September Virtual Investor Conferences– H.C. Wainwright: 22nd Annual Global Investment Conference –September 14th– Cantor Fitzgerald Virtual Global Healthcare Conference –September 17th-Oppenheimer Fall [...]Read More